Finance

Lists
CLRB:NASDAQ
Cellectar Biosciences Inc
$2.58
-0.39%
(-0.0100) 1D
Aug 24, 10:51:16 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CLRB...
Open
$2.56
High
$2.58
Low
$2.56
Mkt. cap
24.39M
Avg. vol.
67.56K
Volume
4.81K
52-wk high
$6.52
52-wk low
$2.20
EPS
-$4.59
Beta
0.55
Shares outstanding
9.45M
No. of employees
11
Open
$2.56
High
$2.58
Low
$2.56
Mkt. cap
24.39M
Avg. vol.
67.56K
Volume
4.81K
52-wk high
$6.52
52-wk low
$2.20
EPS
-$4.59
Beta
0.55
Shares outstanding
9.45M
No. of employees
11
News stories
From web sources and news partners
About Cellectar Biosciences Inc
CEO-
Employees11
Founded1996
HeadquartersFlorham Park, New Jersey, United States
SectorBiotechnology
Websitecellectar.com
Analyst ratings
Based on 3 analysts giving stock ratings to CLRB in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for CLRB in the last 3 months.
Highest
Current $2.58
$15.00 (+481.40%)
Average
$11.67 (+352.33%)
Lowest
$10.00 (+287.60%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
$10.00
+287.6%
08/13/2026
Kevin DeGeeter
Ladenburg Thalmann & Co.
Buy
Reiterated
$10.00
+287.6%
08/14/2026
Kemp Dolliver
Brookline Capital Markets
Buy
Initiated
$15.00
+481.4%
07/12/2026
Jonathan Aschoff
Roth MKM
Buy
Reiterated
$11.00
+326.4%
05/05/2026
Jeff Jones
Oppenheimer
Hold
Maintained
-
-
11/14/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.52M
3.16M
3.01M
4.56M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.33M
2.53M
2.79M
2.64M
Operating expense
4.85M
5.69M
5.79M
7.20M
Total operating expenses
4.85M
5.69M
5.79M
7.20M
Operating income
-4.85M
-5.69M
-5.79M
-7.20M
Other non operating income
294.28K
297.83K
77.00K
132.00K
EBT including unusual items
-4.44M
-5.30M
-5.65M
-6.93M
EBT excluding unusual items
-4.44M
-5.30M
-5.65M
-6.93M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4.44M
-5.30M
-5.65M
-6.93M
Net profit margin
-
-
-
-
Earnings per share
-1.41
-0.53
-1.33
-0.57
Interest and investment income
112.54K
97.58K
63.00K
133.36K
Interest expense
-
-
-
-
Net interest expenses
112.54K
97.58K
63.00K
133.36K
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.80M
-5.64M
-5.74M
-7.16M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps